Doing a little CSI stuff as this company has really piqued my interest. ---> All their statements regarding the FDA are caveated with the word "planned". Basically, investors can't hold them to it. Read the "forward looking statements" section of any SEC filing. "Planned" isn't worth the ink its written with. That doesn't mean it won't happen... but the claims can't be litigated if they don't come to fruition. ----> Dilution as per Friday Subject to Completion, dated November 17, 2023 SAFETY SHOT, INC. 11,607,142 Warrants being offered by the Company 11,607,142 shares underlying the Warrants 442,650 Underwriter’s Warrants 442,650 Shares of Common Stock underlying the Underwriter’s Warrants This prospectus relates to an aggregate of 12,049,792 shares of our common stock, par value $0.001 per share, upon the exercise of the following warrants: (1) 11,607,142 warrants (the “Company Warrants”) to purchase 11,607,142 shares (the “Company Warrant Shares”) and (2) 442,650 warrants to the representative of the underwriters (the “Underwriter’s Warrants,” collectively with the Company Warrant, the “Warrant”) to purchase 442,650 shares (the “Underwriter Warrant Shares,” collectively with the Company Warrant Shares, the “Warrant Shares”). The warrant holders acquired their Warrants and the underlying shares of common stock from us under a Registration Statement on Form S-1 (File No. 333- 258005) (the “Registration Statement”) filed with SEC and declared effective on July 21, 2021. As of the date of this prospectus, the Company Warrants have an exercise price of $1.40 per share of common stock and the Underwriter Warrants have an exercise price of $3.50. We will not receive any proceeds from the sale of Warrant Shares by the warrant holders. Upon the cash exercise of the Warrants, however, we will receive the exercise price of such Warrants, for an aggregate of approximately $17,799,274. The warrant holders may sell all or a portion of the shares of common stock beneficially owned by them and offered hereby from time to time directly or through one or more underwriters, broker-dealers or agents. Please see the section entitled “Plan of Distribution” on page 16 of this prospectus for more information. Our Common Stock is quoted on The Nasdaq Capital Market LLC (“Nasdaq”) under the symbol “SHOT”. As of November 15, 2023, the last reported sales price of our Common Stock on Nasdaq was $2.28 per share, and on November 14, 2023, we had 40,127,783 shares of Common Stock outstanding. -----> And there's this FSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. In May 2023, GBB Drink Lab (“GBB”) now operating under Jupiter Wellness (Nasdaq:JUPW) filed a lawsuit against FSD Pharma and FSD Biosciences, and issued a press release (link below) alleging a material breach of a mutual nondisclosure agreement and trade secret misappropriation. These claims are categorically untrue. GBB’s public statements about its knowledge of this technology are, at best, suspect. GBB’s website states that its own supplement’s alleged efficacy “was established via rigorous blood alcohol content testing on dozens of test subjects,” (emphasis added) rather than any sort of formal, clinical validation effort.2 Further, GBB’s press release states that “Our patented formula accelerates the process of converting alcohol to sugar in the body (link below).”1 But it is well-recognized and understood by the scientific community that at no point in the process of metabolizing alcohol is it converted into sugar. FSD Pharma believes that GBB’s failure to appreciate this basic fact demonstrates a lack of understanding regarding the basics of alcohol metabolism in the body. GBB was recently acquired by Jupiter Wellness, Inc. (Nasdaq: JUPW). In a press release (link below) announcing the closing of the acquisition on August 11, 2023, Jupiter claims that GBB’s proposed product now called Safety Shot “ lowers blood alcohol content by up to 50% in just 30 minutes (link below),”3 another extraordinary claim for which GBB provides no support whatsoever. In 2022 GBB drink lab tried to sell itself to FSD Pharma. During the due diligence process, FSD Pharma determined that GBB’s proposed product did not meet FSD Pharma’s expectations, that GBB did not provide requested information, and that GBB repeatedly tried to change the proposed structure of any deal. Furthermore, FSD Pharma had serious concerns about the patents at issue. ----------------------------------------------------------------------------- And this little blurb: The Company has incurred and expects to continue to incur significant costs in pursuit of its expansion and development plans. As of September 30, 2023 and December 31, 2022, the Company had $4,387,797 and $1,931,068, respectively, in cash and working capital of $3,902,697 and $2,245,979, respectively. These conditions have raised doubt about the Company’s ability to continue as a going concern as noted by our auditors, M&K CPAS, PLLC. ________________________________________________________________________ IMO.... PROCEED WITH CAUTION.
That last little bit there that I highlighted in red.... that was straight off the latest 10Q in case there might be some confusion... ie "our auditors" is referring to THEIR auditors. Not some 3rd party on the outside looking in.
Van thank you for that research. // I am in a pickle here for sure. // This kid is just getting the feeling for investing because he thinks he has TTWO in his account. I keep distracting him so he won't look at a statement./ What the hell am I going to do. I need to slide a big winner into his account to prop up his emotions regarding investing. Now I see why X Gen turned it's back on investing. With all the BS going on and these companies cheating and lying it's very hard to present this whole effort as straight forward. Why did NU go down on good earnings dada? Try answering that one. WHAT STOCK CAN WE GET THIS KID INTO THAT WILL SOAR INTO CHRISTMAS?-- I KEEP SAYING CRSP BUT MOM THINKS IT'S TOO RISKY.. WHICH IS A LARK SHE DOESN'T EVEN KNOW SHE OWNS IT, he he he he he.. This is what I do--- Sneak stuff into people's accounts. Ayyyyyyyyyyyyyyyy. I swear when this kid started I said why not just go crazy and buy options! Try the CRSP into Jan.... he he he he...// But you can't do that-! So I came back with lots of lessons about PE's and growth rates and how the PE should be beneath the growth rate, how you should have insider buying, cash on hand and be buying back shares... then how to read a chart for momentum-- and now of course we have nothing. No stock to buy.
Now don't laugh everyone-- The stk has to be uber cheap (very small acct) which means some of my rules of investing must be ignored... Ok--> I'm thinking the best present you can get for Christmas is a solar truck bed cover. & portable charging battery... Worksport advances COR battery power generator system » 08:18 WKSP Idea #1->WKSP $1.70
--JPMorgan ups Birkenstock target, says buy the recent selloff » 07:07 BIRK --Marqeta price target raised to $8 from $7 at Mizuho » 06:51 MQ --Full Truck Alliance sees Q4 revenue up 18.2%-20.6%, consensus $317.38M » 05:22 YMM --Full Truck Alliance reports Q3 adjusted EPS 11c, consensus 8c » 05:10 YMM --Dutch Bros upgraded to Overweight from Neutral at JPMorgan » 04:50 BROS --Iovance Biotherapeutics initiated with a Buy at Goldman Sachs » 04:37 IOVA //////////////// Never heard of YMM-- it is Chinese road freight<------- Company Profile Full Truck Alliance Co. Ltd., together with its subsidiaries, operates a digital freight platform that connects shippers with truckers to facilitate shipments across distance ranges, cargo weights, and types in the People’s Republic of China. The company offers freight listing, matching, and brokerage services; and online transaction services, as well as various value-added services, such as credit solutions, insurance brokerage, software solutions, electronic toll collection, and energy services. It also provides technology development and other services. The company was founded in 2011 and is based in Guiyang, China.
Son you missed Archer it was a great idea how about some JOBY? JOBY Joby Aviation, Inc.- Chart has promise...Kind of. $6.140.15(+2.50%)4:00 PM 11/17/23 NYSE |$USD |Pre-Market:$6.15+0.01(+0.16%)8:26 AM
See what happens when you're nice... SHOT may still run on momo. I wouldn't put it in his account though. Unless you want to try to time the musical chairs.
Idea #2->IOVAIovance Biotherapeutics, Inc. $5.050.65(+14.77%)4:00 PM 11/17/23 NASDAQ |$USD |Pre-Market:$5.75+0.70(+13.86%)8:51 AM
One of the elements giving PagerDuty an economic moat against competitors is its integration with over 700 technology platforms, such as Amazon Web Services. This allows the company to provide comprehensive monitoring while making it easy to adopt PagerDuty's services. As a result, the company's customer count in its fiscal second quarter, ended July 31, rose 19% year over year to 26,000. Second-quarter sales of $107.6 million were up 19% over the prior year. PagerDuty anticipates revenue growth to reach at least $426 million in its 2024 fiscal year, a 15% year-over-year increase. More than 70% of its second-quarter revenue came from the U.S., leaving ample opportunities to increase sales internationally. PagerDuty's monitoring system PagerDuty focuses on IT infrastructure monitoring to minimize disruption of an organization's crucial systems. Its platform uses AI to identify when various issues are related to the same root cause, to avoid inundating its users with repetitive alerts. PagerDuty, Inc. (PD)- Going to $25 we'll talk then. NYSE - NYSE Delayed Price. 21.77+0.60(+2.83%)